Zdrowie i gospodarka · 06/02/2019
FDA Announces Draft Guidance for Eosinophilic Esophagitis Treatment
The FDA has released a draft guidance document to aid pharmaceutical companies in developing treatments for eosinophilic esophagitis, a condition that affects the esophagus, and invites industry stakeholders to provide feedback.